Anhui Chest Hospital
18
9
9
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 18 trials
100.0%
+13.5% vs industry average
44%
8 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion
Role: collaborator
Confocal Laser Endomicroscopy Guided Medical Thoracoscopy for the Diagnosis of Pleural Disease
Role: collaborator
Diagnostic Performance and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy in Diagnosing Tuberculous Mediastinal Lymphadenitis: a Randomised Controlled Trial
Role: collaborator
TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease
Role: collaborator
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
Role: collaborator
Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease
Role: collaborator
Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT
Role: collaborator
Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer
Role: lead
Value of Bronchoalveolar Lavage with Acetylcysteine in the Treatment of Bronchiectasis.
Role: collaborator
A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB
Role: collaborator
The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)
Role: collaborator
Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis
Role: collaborator
Is Bronchoscopy Necessary in the Preoperative Workup of GGO Lung Cancer?(ECTOP-1005)
Role: collaborator
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Role: lead
Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease
Role: collaborator
Circulating Tumor DNA Methylation Test to Differentiate Benign and Malignant Pulmonary Nodules
Role: collaborator
A Metal Bare Stent With 125 Iodine （125I）Seeds for the Treatment of Malignant Central Airway Stenosis
Role: collaborator
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
Role: collaborator
All 18 trials loaded